Amanote Research
Register
Sign In
Frequency of Mutations Conferring Resistance to Nucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1-Infected Patients in Korea
Journal of Clinical Microbiology
- United States
doi 10.1128/jcm.40.4.1319-1325.2002
Full Text
Open PDF
Abstract
Available in
full text
Categories
Microbiology
Date
April 1, 2002
Authors
Y. K. Cho
H. Sung
S. H. Ahn
I. G. Bae
J. H. Woo
Y. H. Won
D. G. Kim
M. W. Kang
Publisher
American Society for Microbiology
Related search
Combination of Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Required for Resistance to the Carbocyclic Nucleoside 1592U89.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently Under Development as Microbicides
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Antiviral Drug Resistance Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Occur in Specific RNA Structural Regions.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Modulation of Human Immunodeficiency Virus Type 1 Synergistic Inhibition by Reverse Transcriptase Mutations
Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Kinetic Analysis of Intravirion Reverse Transcription in the Blood Plasma of Human Immunodeficiency Virus Type 1-Infected Individuals: Direct Assessment of Resistance to Reverse Transcriptase Inhibitors in Vivo.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Risk Factors for Selection of the L74I Reverse Transcriptase Mutation in Human Immunodeficiency Virus Type 1-Infected Patients
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Comprehensive Mutant Enzyme and Viral Variant Assessment of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Resistance to Nonnucleoside Inhibitors.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Substrate Inhibition of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
